Skip to content

Dr. Cedric Moerman

Active
Private limited companyfounded 2023active for 3 yearsDrabstraat 69, 2550 Kontich, BelgiumKBO/BCE: BE 0803.724.677
Summary

Dr. Cedric Moerman has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €433,849 and a net result of €184,237. Equity is growing by about 71% per year across the filed financial years. Its solvency ranks better than 95% of 20,511 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

History

On 7 July 2023, Dr. Cedric Moerman was incorporated as a private limited company.1 In 2024 the registered office moved to Kontich.2 Total assets went from €108,085 in 2023 to €444,493 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 27-03-2024
  3. 3National Bank, annual accounts 2023 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
18-08
NBB filing Annual accounts filed
financial year 2025 · micro format · 18 days late
2025
31-12
Financial Highest result from 2023 to 2025net €184,237 ▲9.8%
Operating result €241,150, net result €184,237, both a record.
31-12
Financial Liquidity more than 8 timescurrent ratio 36.21
Current ratio from 4.11 to 36.21; short-term debt falls from €57,842 to €10,644.
28-07
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial Equity above €200,000equity €249,612 ▲205%
A profit in every financial year since 2023 builds equity to €249,612.
29-07
NBB filing Annual accounts filed
financial year 2023 · micro format
27-03
Gazette deed Registered office
Registered-office move2 facts ▸
  • Board meeting, 28-12-2023
  • Registered-office move, Drabstraat 69 te 2550 Kontich
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.